ACG, the world’s most integrated provider of solid-dosage and packaging solutions, has announced the launch of DryPod™, a next-generation desiccant-based cold-form laminate engineered to protect highly moisture-sensitive drug molecules.
DryPod™ marks a major advancement for pharmaceutical manufacturers who have long grappled with limited availability, rigid technologies, and compatibility issues within existing desiccant cold-form solutions.
ACG, the world’s most integrated provider of solid-dosage and packaging solutions, today announced the launch of DryPod™, a next-generation desiccant-based cold-form laminate engineered to protect highly moisture-sensitive drug molecules. DryPod™ marks a major advancement for pharmaceutical manufacturers who have long grappled with limited availability, rigid technologies, and compatibility issues within existing desiccant cold-form solutions.
